3/18/2021Complix Agrees with I-Mab to Develop Cell Penetrating Alphabodies aga...

3/18/2021NMPA Revises Packages Inserts of Sodium Ferulate for Injection

3/18/2021Ping An Good Doctor: Cross-Sectional Survey

3/17/2021NHSA Releases Its 2020 Healthcare Security Sector Development Statisti...

3/16/2021CDE Issues the Technical Requirements for Topical Dermatological Gener...

3/16/2021Chinese Chemical Drug Manufacturing Industry Revenue Down Slightly in ...

3/16/2021Italfarmaco Group Agreed with Luye Pharma to Commercialize Rivastigmi...

3/16/2021Pfizer to Halt Biosimilar Production in China and Sell Its Hangzhou Bi...

3/16/2021Remegen Wins China Approval for Lupus Drug Telitacicept

3/16/2021BeiGene Announces Acceptance of a Supplemental Biologics License Appli...

3/16/2021Patent Term Extension in China

3/15/2021Highlights of the 14th Five Year Plan Covers Various Aspects of Health...

3/12/2021CDE Issues the Guidelines for Acceptance and Evaluation of TCM Changes

3/12/2021Recent Executive Moves

3/11/2021NHSA Initiates DRG-based Medical Insurance Payment in Simulation Run

3/10/2021Alphamab's IND for Phase II Pivotal Trial of KN046 Cleared in the U.S...

3/10/2021Wugen Enter Partnership with Alpha Biopharma in Asia for Cell Therapie...

3/10/2021I-Mab Signs Two New Partnerships to Expand Transformational I/O Pip...

3/10/2021ReForm Biologics Announces the Issuance of Chinese Patent for Therapeu...

3/10/2021Multi-source Financing for Tuberculosis Treatment in China: Key Issues...

3/10/2021I-Mab BioPharma and Its Dual Drug Portfolio

3/9/2021Sinopharm Faces Battle to Turn Covid Vaccine into a Global Success

3/9/2021CNIPA Releases Chinese IP Related Statistics in 2020

3/9/2021NHSA Holds Conference, Highlighting Path Forward for Centralized Drug ...

3/8/2021Sorrento's Socazolimab Cleared for Late-Stage Lung Cancer Study in Chi...

3/8/2021CDMO Vetter Opens Office in China to Meet Growing Demands

3/8/2021Winhealth and Merz Collaborate Enter Distribution Pact for Liver Dise...

3/8/2021CStone Forges Strategic Alliance with Sinopharm for Commercialization ...

3/8/2021Eli Lilly Launches Verzenio (Abemaciclib) in China

3/8/2021FT: Pharma Groups Spend Billions to Tap into Booming China Healthcare

Page:98/360 Total number of articles:10791: [First][<<] [96] [97] [98] [99] [100] [>>] [End]